NZ719549B2 - Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder - Google Patents
Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder Download PDFInfo
- Publication number
- NZ719549B2 NZ719549B2 NZ719549A NZ71954912A NZ719549B2 NZ 719549 B2 NZ719549 B2 NZ 719549B2 NZ 719549 A NZ719549 A NZ 719549A NZ 71954912 A NZ71954912 A NZ 71954912A NZ 719549 B2 NZ719549 B2 NZ 719549B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- suspension
- solution
- extracts
- extract
- bees
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000011282 treatment Methods 0.000 title claims abstract description 27
- 238000011321 prophylaxis Methods 0.000 title description 6
- 241000257303 Hymenoptera Species 0.000 claims abstract description 67
- 239000000284 extract Substances 0.000 claims abstract description 64
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000006193 liquid solution Substances 0.000 claims abstract description 30
- 239000006194 liquid suspension Substances 0.000 claims abstract description 29
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000015097 nutrients Nutrition 0.000 claims abstract description 22
- 235000000346 sugar Nutrition 0.000 claims abstract description 22
- 239000000725 suspension Substances 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 21
- 235000013336 milk Nutrition 0.000 claims abstract description 21
- 239000008267 milk Substances 0.000 claims abstract description 21
- 210000004080 milk Anatomy 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 18
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 17
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 17
- 235000006408 oxalic acid Nutrition 0.000 claims abstract description 17
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 17
- 244000124209 Crocus sativus Species 0.000 claims abstract description 16
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 16
- 240000007474 Aloe arborescens Species 0.000 claims abstract description 15
- 235000004509 Aloe arborescens Nutrition 0.000 claims abstract description 15
- 241000335053 Beta vulgaris Species 0.000 claims abstract description 15
- 230000002265 prevention Effects 0.000 claims abstract description 15
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 235000021533 Beta vulgaris Nutrition 0.000 claims abstract description 13
- 240000000783 Origanum majorana Species 0.000 claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 13
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 12
- 235000006297 Origanum majorana Nutrition 0.000 claims abstract description 12
- 239000005844 Thymol Substances 0.000 claims abstract description 12
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 12
- 229960000790 thymol Drugs 0.000 claims abstract description 12
- 235000002431 Monarda citriodora Nutrition 0.000 claims abstract description 11
- 240000001958 Monarda pectinata Species 0.000 claims abstract description 11
- 240000007673 Origanum vulgare Species 0.000 claims abstract description 11
- 244000270834 Myristica fragrans Species 0.000 claims abstract description 10
- 235000010677 Origanum vulgare Nutrition 0.000 claims abstract description 10
- 239000007921 spray Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 30
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 22
- 235000016709 nutrition Nutrition 0.000 claims description 20
- 230000035764 nutrition Effects 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 230000003078 antioxidant effect Effects 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 241001529736 Monarda <angiosperm> Species 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229940008506 origanum majorana extract Drugs 0.000 claims description 3
- 210000001541 thymus gland Anatomy 0.000 claims description 3
- 229910014585 C2-Ce Inorganic materials 0.000 claims 1
- 241000748228 Porophyllum gracile Species 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 22
- 230000001225 therapeutic effect Effects 0.000 abstract description 20
- 239000004615 ingredient Substances 0.000 abstract description 17
- 235000008935 nutritious Nutrition 0.000 abstract description 14
- 239000007864 aqueous solution Substances 0.000 abstract description 13
- 235000015961 tonic Nutrition 0.000 abstract description 13
- 230000001256 tonic effect Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 9
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract description 8
- 150000008163 sugars Chemical class 0.000 abstract description 8
- 244000270673 Pelargonium graveolens Species 0.000 abstract description 7
- 235000017927 Pelargonium graveolens Nutrition 0.000 abstract description 7
- 230000009467 reduction Effects 0.000 abstract description 7
- 229960000716 tonics Drugs 0.000 abstract description 7
- 239000007900 aqueous suspension Substances 0.000 abstract description 6
- 125000003118 aryl group Chemical group 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 150000007524 organic acids Chemical class 0.000 abstract description 5
- 235000005985 organic acids Nutrition 0.000 abstract description 5
- 230000007257 malfunction Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 description 31
- 208000024780 Urticaria Diseases 0.000 description 21
- 241000256844 Apis mellifera Species 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 238000009472 formulation Methods 0.000 description 19
- 235000006708 antioxidants Nutrition 0.000 description 18
- 241000256837 Apidae Species 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 241000238876 Acari Species 0.000 description 11
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 241000238631 Hexapoda Species 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 241000894007 species Species 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000012907 honey Nutrition 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 241000256836 Apis Species 0.000 description 5
- 241000256846 Apis cerana Species 0.000 description 5
- 238000009341 apiculture Methods 0.000 description 5
- 244000144987 brood Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 4
- 241001126829 Nosema Species 0.000 description 4
- 208000005374 Poisoning Diseases 0.000 description 4
- 241001558516 Varroa destructor Species 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 230000010152 pollination Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 241000498779 Myristica Species 0.000 description 3
- 241000208181 Pelargonium Species 0.000 description 3
- 241000218657 Picea Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000895647 Varroa Species 0.000 description 3
- 229940077731 carbohydrate nutrients Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 210000001520 comb Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000012456 homogeneous solution Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000002663 nebulization Methods 0.000 description 3
- 235000018343 nutrient deficiency Nutrition 0.000 description 3
- 235000004252 protein component Nutrition 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- 241000317943 Acute bee paralysis virus Species 0.000 description 2
- 241000256848 Apis florea Species 0.000 description 2
- 235000004237 Crocus Nutrition 0.000 description 2
- 241000596148 Crocus Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 241000208152 Geranium Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000122990 Nosema ceranae Species 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 241001529744 Origanum Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000012271 agricultural production Methods 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 2
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 2
- 235000007746 carvacrol Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 244000037671 genetically modified crops Species 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- BNWJOHGLIBDBOB-UHFFFAOYSA-N myristicin Chemical compound COC1=CC(CC=C)=CC2=C1OCO2 BNWJOHGLIBDBOB-UHFFFAOYSA-N 0.000 description 2
- 239000001702 nutmeg Substances 0.000 description 2
- 235000020731 origanum vulgare extract Nutrition 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000002311 subsequent effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 244000052613 viral pathogen Species 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- -1 vitamin compound Chemical class 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- NGGMYCMLYOUNGM-UHFFFAOYSA-N (-)-fumagillin Natural products O1C(CC=C(C)C)C1(C)C1C(OC)C(OC(=O)C=CC=CC=CC=CC(O)=O)CCC21CO2 NGGMYCMLYOUNGM-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000351 Acariasis Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 241000256845 Apis dorsata Species 0.000 description 1
- 241000015607 Apis mellifera carnica Species 0.000 description 1
- 241001144658 Apis mellifera caucasica Species 0.000 description 1
- 241000256843 Apis mellifera ligustica Species 0.000 description 1
- 241000179993 Apis mellifera mellifera Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 241000748655 Invertebrate iridescent virus 6 Species 0.000 description 1
- 241001163131 Israeli acute paralysis virus Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 235000008094 Monarda citriodora var citriodora Nutrition 0.000 description 1
- 244000299823 Monarda citriodora var. citriodora Species 0.000 description 1
- 241001492486 Nosema apis Species 0.000 description 1
- WMHJCSAICLADIN-MVVLZTAMSA-N Picrocrocin Natural products O=CC=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)CC=1C WMHJCSAICLADIN-MVVLZTAMSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 235000019772 Sunflower meal Nutrition 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 description 1
- 229960005327 acemannan Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 230000010138 bee pollination Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- NGGMYCMLYOUNGM-CSDLUJIJSA-N fumagillin Chemical compound C([C@H]([C@H]([C@@H]1[C@]2(C)[C@H](O2)CC=C(C)C)OC)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)C[C@@]21CO2 NGGMYCMLYOUNGM-CSDLUJIJSA-N 0.000 description 1
- 229960000936 fumagillin Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021306 genetically modified maize Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010211 insect pollination Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- WMHJCSAICLADIN-WYWSWGBSSA-N picrocrocin Chemical compound C1C(C)=C(C=O)C(C)(C)C[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WMHJCSAICLADIN-WYWSWGBSSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
Abstract
automated apparatus for the prevention and treatment of the Colony Collapse Disease (CCD) through the administration of nutrients and therapeutic to bee colonies to be treated comprises a box-like container (10) of a material resistant to atmospheric agents which accommodates in its interior at least a first reservoir (9) being liquid-tight fitted with a stirrer (12) and accessible from the outside through a first nozzle (4), an atomizing device (15) of a liquid solution or suspension of nourishment contained in the tank, means for the delivery (2, 1) of the liquid solution or suspension atomized into micrometric drops outside the apparatus, and a control unit (7) programmed for timing the delivery of the solution or suspension to the outside, for the determination of the amount of solution or suspension delivered and for emitting alarm signals in case of malfunctions of the apparatus or reduction of the solution or suspension in a liquid contained in the reservoir (9) below a predetermined level. The apparatus is powered by direct current with the energy supplied by a solar panel (5) located outside of the container and electrically connected to the control unit (7). Further disclosed is a liquid solution or suspension of nutrients that can be delivered in a spray form through the above deceived automated apparatus for the prevention and treatment of the Colony Collapse Disease (CCD). The solution or suspension comprises in a single aqueous solution or suspension of a) tonics and nutritious ingredients, mainly consisting of: milk powder and/or yeasts, sugars and lower organic acids; b) natural antioxidants and antiseptics contained in the extracts of one or more aromatic or medicinal plants selected from: Crocus sativus, Pelargonium graveolens, Monarda citriodora, Myristica fragrans, Origanum vulgare and Origanum majorana; and c) substances medicinal to bees, selected from thymol, oxalic acid, extracts of Thymus vulgaris, extracts of Aloe arborescens, extracts of Beta vulgaris cv. altissima and mixtures of two or more of the same. Also disclosed is a method for the prevention and treatment of the Colony Collapse Disease (CCD) through the administration of nutrients and therapeutic to bee colonies to be treated, consisting in using the above described automated apparatus deliver in a spray form, the above described solution or suspension. east a first reservoir (9) being liquid-tight fitted with a stirrer (12) and accessible from the outside through a first nozzle (4), an atomizing device (15) of a liquid solution or suspension of nourishment contained in the tank, means for the delivery (2, 1) of the liquid solution or suspension atomized into micrometric drops outside the apparatus, and a control unit (7) programmed for timing the delivery of the solution or suspension to the outside, for the determination of the amount of solution or suspension delivered and for emitting alarm signals in case of malfunctions of the apparatus or reduction of the solution or suspension in a liquid contained in the reservoir (9) below a predetermined level. The apparatus is powered by direct current with the energy supplied by a solar panel (5) located outside of the container and electrically connected to the control unit (7). Further disclosed is a liquid solution or suspension of nutrients that can be delivered in a spray form through the above deceived automated apparatus for the prevention and treatment of the Colony Collapse Disease (CCD). The solution or suspension comprises in a single aqueous solution or suspension of a) tonics and nutritious ingredients, mainly consisting of: milk powder and/or yeasts, sugars and lower organic acids; b) natural antioxidants and antiseptics contained in the extracts of one or more aromatic or medicinal plants selected from: Crocus sativus, Pelargonium graveolens, Monarda citriodora, Myristica fragrans, Origanum vulgare and Origanum majorana; and c) substances medicinal to bees, selected from thymol, oxalic acid, extracts of Thymus vulgaris, extracts of Aloe arborescens, extracts of Beta vulgaris cv. altissima and mixtures of two or more of the same. Also disclosed is a method for the prevention and treatment of the Colony Collapse Disease (CCD) through the administration of nutrients and therapeutic to bee colonies to be treated, consisting in using the above described automated apparatus deliver in a spray form, the above described solution or suspension.
Description
COMPLETE SPECIFICATION
Method, apparatus and compositions for the prophylaxis and ent of colony
collapse disorder
We, BeesFree Inc., of 2101 Vista Parkway, Suite 4033, West Palm Beach, 33411, Florida,
United States of America hereby declare the invention, for which we pray that a patent may
be granted to us and the method by which it is to be med, to be particularly described in
and by the following statement:
(followed by page 1a)
METHOD, APPARATUS AND COMPOSITIONS FOR THE PROPHYLAXIS
AND TREATMENT OF COLONY COLLAPSE DISORDER
DESCRIPTION
Technical Field
The present invention concerns a method for preventing and treating
Colony Collapse Disorder, an apparatus for implementing such a method and
nutritious and therapeutic itions to be distributed to the bees to be
’IO treated by this method. More specifically, the invention relates to a device that
dispenses, in an automated way, a specifically calibrated diet for ption
by one or more colonies of icated honey bees, in substitution or in
addition to natural nourishment that the insects derive from their normal activi-
ty of collecting and processing nectar, pollen and other natural materials. The
consumption of nutrients and therapeutics according to the method proposed
helps the treated bees to resist the e known as "Colony Collapse Disor-
der .
Background of the invention
Bees are the kind of social insects most appreciated and studied since
ity, whose ness is certainly known since prehistoric times. As
other insects in the family of Apidae, bees collect nectar and pollen to feed
their offspring and to store them in their combs as food storage.
While it is not the only group of ators ts which, with their
activities, carry pollen from flower to flower allowing pollination and the subse-
quent formation of the fruit), honey bees are undoubtedly the most important
one for humans, also for the various products that their colonies develop from
nectar and other materials collected by foraging, including not only honey, but
also beeswax, propolis, royal jelly. Unlike other social apidae like bumblebees,
which perform similar functions as pollinators useful to agriculture but most of
which do not survive the winter (with the exception of fertilized queens), the
bees accumulate and process amounts of food stocks to be sufficient to pass
[followed by page 2]
_2_‘
the winter, because their colony is able to winter along with their queen, which
can live 4-5 years.
For these reasons, bees have been used since the dawn of zation
as real pets, and were reared according to ancestral and consolidated tech-
niques over time, applying a knowledge which is a branch of animal husband-
ry, beekeeping.
Although the known species of the Apidae family are currently about
five nd, the genus of bees (Apis) is only one. It comprises only seven
species recognized as distinct species, the best known of which are Apis
era ean honeybee), Apis cerana (Eastern honey bee or Asiatic
honey bee), Apis florea (dwarf honeybee, widespread in South Asia and
Southeast Asia) and Apis a (giant honey bee of India). Only the first two
species, Apis mellifera and Apis cerana, can be bred by humans and are
actually made "domestic", the first one at least from the times of ancient Egyp-
tians.
Apis mellifera is the most widespread species of the genus Apis in the
world: native to Egypt, it spread millions of years ago in the Mediterranean
and in tropical Africa, and then in the presence of man it naturally populated
Europe, Africa, middle East and part of Siberia. it was introduced in the seven—
teenth and nineteenth y also in the American continent, where it was not
originally present, and it was also brought in Australia and New Zealand by
the colonizers. The most well-known European subspecies of Apis mellifera
are identified by geographic areas, separated by mountains that swarms may
not overcome, where they are native and have lived with a few al con—
tacts. There are tly 28 recognized subspecies of Apis mellifera, which
include the black bee (Apis mellifera mellifera), native of northern Europe, the
Italian yellow honeybee (Apis mellifera ligustica), which occupies most of Italy,
the lan bee (Apis mellifera Carnica) which is native to Austria and Slo-
venia, the Caucasian bee (Apis mellifera caucasica), which lives mainly in the
Caucasus and Georgia, and so on. Mixed breeds and hybrids have been
created by human action, either voluntary or not.
In sedentary beekeeping, hives are fixed and the area of collection of
the bees does not exceed 2 or 3 km radius around the hive, which sets limits
to the collection. For this reason it is also practiced nomadic beekeeping,
which involves moving the hives from site to site, depending on the presence
of nectar—producing plants (i.e. sugar bases to be provided to the bees). Such
movements, in addition to increasing the productivity, allow the tion of
single-flower honeys, allowing a better offer of the final product.~ The trans—
humance is a very ancient farming que, already practiced by nomads,
who carried their hives on the back of an animal. in Italy on the Po, as in
Egypt on the Nile, the hives were loaded onto special boats that sailed up the
river toward regions with the most favorable honeydew. When a certain water-
line was reached, the hives were full. Currently the movement of hives occurs
on the road: they are loaded at nightfall (when all the bees have returned to
the beehive) and are downloaded at sunrise in the new site. The hives are
often downloaded and re-housed in the new area chosen for the pasture, but
sometimes, in order to reduce maintenance work, the hives are left directly on
vehicles equipped for this purpose.
As already noted, the bees play a vital role in the reproduction of
plants with entomophilous pollination. To understand the role of bees in agri—
culture around the world it is enough to er that the Food and Agriculture
Organization of the United Nations (FAO) has estimated that 71 out of the 100
species of plants that provide 90% of the food worldwide are associated with
bee pollination. Over the last fifty years, the agricultural production nd-
ent from insect pollination has doubled, and the agricultural production that
requires pollination by insects has increased fourfold, thus indicating that
world lture has become more pollinator—dependent. Both the FAO and
other independent research organizations of this field have ted that the
economic value of pollination worldwide for agriculture and related sectors is
of the order of 180 billion US. dollars, of which 32 billion s are in the
United States.
it is known that the population cs of a bee colony is significant—
ly nced by the nutritional status of the colony, which controls the devel-
opment, tion and survival of the colony. it is also well known that the
necessary food for bees are carbohydrates, proteins, lipids and vitamins:
carbohydrates e energy and are contained in nectar and honey, the
other substances are present in pollen and are essential both for the produc-
tion of larval food and for a ed functioning of the bee’s life. In recent
years, for various reasons (including illness, poisoning, reduction of foraging
areas, etc..) it has often become an indispensable requirement for the bee-
keeper to intervene with additional nutrition, which favors the survival of the
hives or prepares them for a certain flowering i F. et al., Confronto tra g/i
effetti di diversi tipi di alimento per le api, ario ERSA 3/2009). Sugar
nutrition is the most practiced by beekeepers; it consists of delivering syrups
or s (obtained from sugars from various sources) with the aim of integrat-
ing the energy needs of the bees. in relation to the needs and to the admin-
istration time, sugar nutrition can be "stimulant", if carried out to increase the
egg laying by the queen or to induce the colonies to recover after stress fac—
tors (poisonings, diseases, swarming, environmental adversity), or "compen-
satory", if the aim is to build up the winter stocks to avoid starvation of hives
during periods of low availability.
Protein nutrition, which compensates for a lack of pollen, is a less
applied nutrition technique, but sometimes it can be of vital importance to a
colony of bees: in fact, the lack of pollen may entail a reduction of the bees’
longevity and the ion or total blockade of the brood, with consequent
depopulation and collapse of the colonies. It should be kept in mind that in no
case an artificial stration of proteins is able to completely replace pol-
len, and has s only if it is carried out for a limited period of time.
Protein feeding can be done by ing the hives with (preharvested
) pollen, by integrating the pollen with (up to 25% by weight of) an
artificial protein component (supplemental n nutrition) or by administer-
ing only cial protein components (substitute protein nutrition). Very often
various protein components (soybean meal, sunflower meal, yeast, milk pow-
der, etc.) are mixed together to achieve higher nutritional value, but it is im—
portant that the total quantity of protein food preparation be between 10 and
wt%, as higher values can lead to toxic effects on bees.
Protein nutrition can be supplied by placing the powdered food outside
the hive in special containers, or by placing the mixture inside the hive in deep
frame feeders, or in patties over the combs, covered by the outer cover. In the
latter case the food protein is almost always added with honey or sugar syrup
until a pasty and semi-solid candy—like consistency is obtained ("protein
cake").
With reference to the choice of an appropriate food for a colony of
honeybees, the international Patent Application publn. No.
(The United States of America as Represented by the Secretary of Agri-
culture) having title "Artificial diets for domestic honey bees" discloses water
dispersible preparations consisting of neous mixtures of nutrients in
effective amounts and tions to support growth and development of
domestic bees. The proposed formulations are considered particularly advan-
tageous for feeding bee colonies that are moved frequently from one area to
another: in the absence of sufficient natural ces, such as, e.g., during
the ers, the cial diet preparations proposed should be able to pro-
vide all the necessary nutrients for the life of the colony. The components
required in the described nutritional composition are proteins, lipids, carbohy-
drates, ash, cholesterol, ascorbic acid, an acidifier, an antimicrobial/ antifungal
agent for the preservation of the mixture and water, in the appropriate propor-
tions. As a source of ns and lipids soy and/or egg are proposed.
One of the major problems of the apiary is to safeguard the health of
the colonies. The honey bee diseases that may p are numerous, as a
result of several pathogenetic organisms, including parasite insects, unicellu—
lar fungi, bacteria and viruses which can affect the bees in the different stages
of their development.
The two best known pathogens to the beekeepers are Varroa destruc-
tor mite and Nosema apis poridium. The Varroa mite is an external
parasite, which attaches at the body of the bee and weakens it by sucking its
hemolymph. During this process the mite may also it viral RNA agents
to the bee. The Varroa mite was found also on other pollinator insects, such
as bumblebees, beetles and files, but it can only reproduce in a colony of
honeybees. Once in the colony, the female mite enters a brood cell of honey
bees, giving preference to a cell containing a male brood, Le. a drone larva.
Once the cell is capped, the mite lays its eggs, after which the young mites
hatch more or less at the same moment as the young bee develops, and
leaves the cell with its host.
The population cs ghted above shows that a large popu—
lation of mites in autumn could lead to a crisis when drones rearing ceases
and the mites turn to the larvae of worker bees, causing a rapid decimation of
the population and often the death of the hive. For this reason the varroa mite
is the parasite with the most pronounced economic impact in the apiary indus—
try.
To fight or prevent the infestation by Varroa destructor different physi-
cal or mechanical methods are known and used to control the number of mites
in the colony, as well as miticide products, both synthetic (pyrethroids, organ-
ophosphates) or of natural origin, such as oxalic acid-based preparations, or
preparations based on thyme essential oil (or on tic thymol).
The unicellular fungus Nose-ma apis (more ly found in a similar
form also in Apis cerana, and called in this circumstance Nosema ceranae) is
characterized by a dormant state consisting of spores resistant to changes in
temperature and humidity. The nosema , in fact, cannot be destroyed
by freezing the contaminated combs. The spores are localized in intestinal
epithelial cells and other cells of adult bees, where they begin the growth,
heading for a series of cell divisions, invading the intestinal tract and thus
causing the pathology known as sis. This is manifested by dysentery
ced by yellowish ngs outside the hive, a slow growth of the colo-
ny, disjointed wings and distended abdomen in affected duals. The ma-
ture spores come out with the feces, contributing to the propagation of the
disease.
lf untreated, the nosema infection may reach the queen, causing an
early replacement of the queen by workers remained healthy. The disease
hinders the digestion of pollen, and therefore reduces the life of bees, and can
be fought with greater difficulty in colder climates, where bees spend more
time in the hive. In order to reduce the infection beekeepers use to increase
the aeration in the hive and remove, as much as possible, the honey gathered
by the bees for winter, feeding them with sugar solutions in replacement. The
pharmacological treatments available in case of need are based on fumagillin,
an antibiotic that was shown to be particularly effective for inhibiting the repro-
duction of spores in the host, but is not able to kill them. Spores can be inacti-
vated, in the disinfestation of the beehive, by treating them with acetic acid or
formalin.
Other pathogens for Apis mellifera which have been investigated for
1O their possible involvement in recent episodes of honeybees epidemics are
viral agents, ing the Acute Bee Paralysis Virus (ABPV or APV), which is
considered to be a common ive agent of bees, and a virus related to the
previous one, described in 2004, known as i Acute Paralysis Virus
(lAPV) due to the fact that it was identified in Israel for the first time. It was
considered that the lAPV virus plays a critical role in cases of sudden collapse
of honeybees colonies infested by the parasite mite Varroa destructor.
r viral pathogen recently studied for similar s is the in-
rate iridescent virus type 6 (llV—6), which was identified in 2010 as a co-
infectious agent in several colonies of honey bees sed as a result of
ion by Nosema ceranae.
Over the last twenty years, parasite mites have certainly caused se—
vere damage to beekeeping, also in view of the fact that they transmit harmful
viruses to bees, therefore causing significant losses of colonies each year.
r, while most of the deaths during the winters of 2006/07 and
2007/2008 were mainly uted to parasitic mites, about 25-30% of dead
colonies showed symptoms contrasting with mites or any other known cause.
Considering for instance the United States, in the thirty years from
1976 to 2006 there has been a drastic reduction in the number of wild bees
(now almost extinct in the U.S.), and a significant, though gradual, decline in
the number of families kept by beekeepers. This latter number, according to
official data, declined from about 6 million in 1940 down to 2,3 million in 2008.
This decline includes the cumulative losses from all factors such as urbaniza-
tion, pesticide use in agriculture, acariosis and , beekeepers’ retirement
and closure of businesses. However, between late 2006 and early 2007, the
reduction rate has increased sharply, reaching tions hitherto n,
and the term y Collapse Disorder" (CCD) was coined at that time to
describe these sudden disappearances.
With Colony Collapse Syndrome beekeepers around the world are
facing one of the toughest nges in decades: to date a constant presence
of colonies of healthy bees cannot be guaranteed, as a combination of caus-
es, currently not fully understood, is more and more often causing mass
deaths of bees. It is a phenomenon not well known that, as noted, has been
found for the first time in the colonies of bees in North America at the end of
2006, and that manifested itself in similar phenomena in Europe in subse—
quent years, for which families of bees (Apis mellifera) abruptly ear.
Possible causes that have been suggested for CCD comprise man-
agement practices of the beekeepers, especially the stress on the colonies
due to environmental changes, malnutrition and nutritional deficiencies asso—
ciated with the presence of ive monocultures, heavy use of new neon—
icotinoid—based pesticides and related practices and procedures for applica—
tion, various pathogens such as infestation by parasite mites, nosema infec—
tions and viral infections (including lAPV virus), climate change, electromag-
netic radiation from mobile phones or other devices created by man, genet-
ically modified crops (GMOs) such as GM maize, new exotic pests and patho-
gens, decreased immunity to pathogens, and the subtle interactions between
two or more of these factors. it is not yet known whether only one of these
factors may be the real sible factor, or it is a combination of factors
which act independently in different areas affected by CCD, or factors that act
in combination with each other, although more recent information suggest that
a combination of several factors is the most likely hypothesis.
As a result of the foregoing, Colony Collapse Disorder was defined as
a new syndrome of multifactorial kind which leads to the death of a very large
number of colonies of bees, and that caused, from 2007 to date, losses of
es greater than 35% per year. With regard to the diagnosis, a colony
which has collapsed from CCD tends to show all of the following signs:
a) presence of a brood of abandoned larvae (usually bees do not aban-
don the brood until they are all hatched);
b) presence of food stores, both pollen and honey, which
- are not immediately robbed by other bees,
— when they are attacked by other insects, the attack is noticeably de-
layed;
c) presence of the queen in the beehive (otherwise, the phenomenon is
not attributable to CCD).
At present there are no known treatments or specific solutions for the
prevention and treatment of Colony Collapse Disorder, nor methods, tech—
niques or procedures exist which the beekeeper can put in place with a rea-
e expectation of success to protect his hives from such a sudden, partly
ained event, as is the se of a colony from CCD.
In the light of the foregoing, the present invention is therefore aimed at
providing a method for the tion and the treatment of Colony Collapse
Disorder in colonies of domestic honeybees that have not already undergone
an episode of irreversible se, with a view to safeguarding the health of
those families which have not yet been affected by the syndrome, and to im-
prove the immune resistance and overall nutritional conditions of domestic
bees.
Summary of the invention
In the framework of the research that led to the present invention, it
has been considered that, although not yet fully understood in its triggering
mechanisms, CCD is most likely a syndrome of actorial kind, and there—
fore an ive treatment must start from a general good health state in the
colony and from the elimination of any ility of nutritional deficiencies
which may lead to ng the immunity defenses.
Furthermore, considering that the acariasis from Varroa destructor
and the endemic presence of Nosema, as well as that of viral pathogens such
as IAPV and llV-6, together with the effects of poisoning by the new genera-
tion pesticides (in particular, neonicotinoids) are among the most nt or
most likely causes of colonies’ weakening, according to the present ion
a method of prophylaxis and treatment of CCD in colonies of honeybees is
being ed, which method consists of regularly feeding the bees to be
treated with a specifically formulated nutritional and therapeutic composition in
aqueous solution, by means of an equipment designed for that purpose.
The treatment method proposed according to the invention is d
out through an automated equipment to be positioned in ity to the hive,
which allows the nebulization of a preparation (where by nebulization the
transformation of a liquid into an aerosol having very fine drops is meant), the
latter representing a further aspect of the invention, made with ingredients with
high nutritious, tonic, antioxidant and healing activities. The invention therefore
concerns both the proposed apparatus for nebulizing the therapeutic and
nutrient preparation and the formulation in terms of components of the prepa-
ration .
The solution or aqueous suspension to be distributed to the bees
according to the ion is obtained through the optimal combination of: a)
nt and tonic ingredients mostly based on powdered milk and/or yeast,
sugar and lower organic acids, b) natural antioxidants and antiseptics having
high activity, ned in extracts of some plants known for their herbal prop-
erties, and c) therapeutic substances for bees, such as the extract of Thymus
vulgar/s, having the ability of preventing or countering the proliferation of ecto—
te mites and fungal forms harmful to bees. The combination of ingredi-
ents proposed is able to prevent nutritional deficiencies, to safeguard the
health conditions of the colonies treated and at least partially counteract the
effect of contamination by pesticides such as neonicotinoids, thus drastically
reducing the risk of contracting CCD or mitigating the effects thereof.
In one aspect, there is provided a liquid solution or suspension deliverable in a
form of a spray for the prevention and ent of Colony Collapse Disorder
(CCD), the liquid solution or suspension comprising:
a) a nutrition composition comprising milk powder, a sugar, C2—C6 or-
ganic acid and optionally yeasts;
b) an antioxidant and antiseptic composition comprising an t of
Origanum vulgare and an extract of at least one plant selected from the group
consisting of Crocus sativus, Pelargonium graveo/ens, Monarda citriodora, ,
Myristica fragrans, and Origanum majorana; and
c) a medicinal composition for bees comprising at least one selected
from the group consisting of thymol and extracts of Thymus vulgaris, and at
least one selected from the group consisting of extracts of Aloe arborescens,
oxalic acid, extracts of Beta vulgaris cv. altissima and mixtures thereof.
In a further aspect, there is provided a method for the prevention and treat-
ment of Colony se Disorder (CCD) h the administration of nutri—
ents and eutic substances to bee colonies to be treated, comprising
ring a liquid solution or suspension in a form of a spray, the liquid solu-
tion or suspension comprising:
a) a nutrition ition sing milk powder, a sugar, C2-CB or-
ganic acid and optionally yeasts;
b) an antioxidant and antiseptic composition comprising an extract of
Origanum vulgare and an extract of at least one plant selected from the
group consisting of Crocus sativus, Pelargonium graveolens, Monarda citri-
odora, Myristica fragrans, and Origanum majorana; and
c) a nal composition for bees comprising at least one selected
from the group consisting of thymol and extracts of Thymus vulgaris, and at
least one selected from the group consisting of extracts of Aloe arbo-
rescens, oxalic acid, extracts of Beta vulgaris cv. altissima and mixtures
thereof.
Brief description of the drawings
The specific features of the invention, as well as the advantages of the
same and their operational modes, will be apparent with reference to the de-
tailed description ted below, and to some specific embodiments of the
nt dispensing device, illustrated by way of example in the accompanying
gs. In the accompanying drawings,
Figure 1 is a functional scheme of a first embodiment of the dispens-
ing apparatus according to the invention for the automated delivery of a thera-
peutic and nutrient ation for CCD to the colonies of bees to be treated;
Figure 2 is a perspective view of a second embodiment of the dis-
pensing apparatus for a therapeutic ad nt preparation for CCD according
to the invention.
Detailed description of the invention
Therefore, the present invention specifically provides an automated
equipment - to be positioned in the proximity of the hive - for the prevention
and treatment of Colony Collapse Disorder (CCD) h the administration
of nt and therapeutic substances to bee colonies to be treated, said
apparatus comprising a boxlike ner made of a al resistant to at-
mospheric agents, which accommodates in its interior at least a first liquid-
tight reservoir fitted with a stirrer, and accessible from the outside h a
first inlet neck, a nebulizing device for a liquid solution or suspension of nour-
ishment contained in said first reservoir, means for sing the liquid solu-
tion or suspension nebulized into micrometric drops outside the apparatus,
and a control unit programmed for timing the delivery of the solution or sus—
pension to the outside, for dosing the amount of solution or suspension dis-
pensed and for emitting warning signals in case of ctioning of the appa—
ratus or reduction of the liquid solution or suspension contained in the first
reservoir below a preset level, said apparatus being powered in DC by energy
supplied by a solar panel placed on the exterior of said boxlike container and
electrically connected to said control unit.
According to a preferred embodiment of the apparatus of the inven-
tion, the means for dispensing the nebulized liquid solution or suspension to
the exterior include a container or feeding chamber accessible to the bees but
sheltered from the external environment, for example similar to those n—
ers used as rs" to be positioned on top of the outer cover in convention-
al hives, but with an entrance for the bees provided from the e. It is also
possible to provide, above the container/feeder itself, a cover having the func-
tion of a sunscreen, preferably colored in bright and floral colors, in order to
better attract bees to the food source.
According to other preferred embodiments, the means for dispensing
the nebulized liquid solution or suspension outside of the apparatus also in-
clude a telescopic tube extensible in length upwards, placed between the
boxlike container of the apparatus and said container or feeding chamber,
which allows to adjust the height of the point of delivery of the nutritious and
therapeutic preparation of the invention.
Preferably, the proposed tus according to the invention com-
prises a second reservoir inside said boxlike container, having r volume
than the first reservoir, in communication with it and separately accessible
from the outside through a second inlet neck. The two separate accesses
permit to reintegrate ndently an aqueous concentrated solution or suspension
of the nutritious and therapeutic preparation ing to the inven-
tion through the second inlet neck, while the first inlet neck is used only for the
connection to the water supply.
The boxlike container of the apparatus proposed is conveniently made
of material resistant to atmospheric agents, for e similar to the material
of the hives near which it must be placed, and it is preferably externally col-
ored with one or more colors that are attractive to pollinator insects, such as
purple, blue, red or green. Preferably, said container is made of seasoned
spruce wood, externally painted in the above mentioned colors.
To further tate the management of the ted treatment, the
apparatus according to the invention may comprise further l devices in
addition to those already mentioned, compatibly with the cost of such equip—
ment. In particular, it may comprise one or more temperature and/or pH sen-
sors, or multiparameter s, located inside the main reservoir, and the
control unit may be programmed to r the measured values of the rela-
tive magnitudes and to emit alarm signals in the event that these values go
beyond the set limits.
As it has to be oned on the ground in the proximity of the bees
colonies to be treated, the apparatus according to the invention preferably
comprises four wheels placed below the boxlike ner, and one or more
handles for manually oning said apparatus, so as to enable the bee-
keeper to move it in the most favorable place in relation to the hives, the water
supply location, the position of the sun, and other requirements that may vary
during the season or depending on other events.
The apparatus according to the invention is also described in the two
exemplary embodiments illustrated in Figures 1 and 2 of the accompanying
drawings (where corresponding elements are indicated with the same refer—
ence numerals). The apparatus consists of a special and automated nebuliz—
ing system to be installed in the ity of the colonies or hives in order to
facilitate the accessibility to the nebulized liquid preparation, through the appa—
ratus, by the families of bees to be subjected to the treatment.
The system is composed of a box or container (10), for example
equipped with wheels (13) and handle (14) to allow its positioning, and having
a color suited to attract the bees and/or to be viewed by them, for example, in
, blue, red or yellow. The container (10) can be realized in different
materials, possibly recyclable, such as seasoned spruce wood or other timber
le for the outdoor permanence and for the exposure to sunlight and rain.
inside the container (10) a first gas—tight reservoir (6) is housed, hav-
ing a volume from a minimum of 2 liters to a maximum of 20 liters, in which
there is poured, through the inlet neck (3), the trate prepared according
to the invention with ed ingredients, later detailed, and that allows the
correct dosage of the ingredients themselves.
In a second gas-tight reservoir (9), having a volume from a minimum
of 20 liters to a m of 35 liters, ng water is loaded through the inlet
neck (4), possibly water with low ss, by which the content of the first
reservoir (6) will be diluted. Alternatively, a single reservoir may be used, in
3O which both water and the therapeutic and nutritious preparation to be diluted
are loaded.
In the case where the reservoirs designed are two, they are connect—
ed together h a pipe (11) and are supported on one another by means
of supporting elements (8). On the bottom of the larger reservoir (9) (in the
case of two reservoirs) or of the only reservoir (in the case of a single reser-
voir) there is a mixer (12) which is activated for short periods of time (generally
few minutes) and allows the preparations to be maintained mixed thus avoid—
ing any form of sedimentation on the bottom.
The periodic bution of the preparation according to the invention
to the bees to be treated is carried out by nebulization of the preparation
through special dispensing nozzles, preferably placed within a feeder-type
container (1) similar to those normally used in the apiary in covercombs, but
accessible to the bees from the outside, for example, through the opening
(17). The zation occurs through a nebulizing device (15) powered in DC,
by means of rechargeable batteries which in turn are fed by a 5 W to 15 W
solar panel (5), installed on the equipment, working at from 4,5 volts up to a
maximum of 12 volts. The electrical zation system that rizes the
contents of the reservoirs (6) and (9), or the one reservoir, is equipped with a
telescopic tube (2) having, for example, a length up to 150 cm. The telescopic
tube (2) allows to place at the optimum height the dispensing s, which
emit a micrometer mist (aerosol) consisting of the preparation in aqueous
solution or suspension according to the invention.
As already noted, the energy required to operate the equipment is
supplied by a solar panel (5), which allows to use the equipment also in open
country and where there is no available fixed power supply. Therefore, the
or using the equipment, after placing it in the optimal place in the prox-
imity of the hives, has only to fill the reservoir with water and pour the mixture
according to the invention. The preparation should be ed approximately
every 2—3 months, while the water level is not to be reintegrated more than
once a month.
Thanks to an electronic control system (7) present in the tus
and to a programmed timer, the nutritious and therapeutic preparation accord-
ing to the invention is sprayed periodically and made available to the bees in
micronized drops of solution or suspension. The control system (7) also allows
—16-
to check the water and the nutritious and therapeutic preparation levels, and
notifies the user, by means of a light and/or sound , and by sending
onic messaging and/or e—mail, when a reservoir reaches the minimum
level. The electronic control system (7) tes in the same way the nebuliz-
er module efficiency (in particular, the possible clogging of the nozzles), by
ing an abnormal electric absorption by the nebulizing system or, alterna-
tively, by means of a pressure device which shows an se of pressure at
the nebulizer itself, which is a symptom of inlet s clogging.
The control system (7) also allows to detect and report general anom-
1O alies of the timing system (which may be digital or mechanical with mobile
switches), of the solar panel (5) functioning or the batteries charge . The
control system (7), which can also be a simple PLC (programmable logic con—
troller), acquires the data of the multiparameter probe (16), with alarm for
temperatures below 0°C and possible cation of the pH of the solution to
be nebulized, to control the exact dosage of the components of the prepara-
tion according to the invention in relation to water.
The control system (7) can be further equipped with an interface for
remote control and verification that allows programming or management of the
alarm signals through smartphone applications, so as to have access to data
24 hours a day, and especially to be able to check the proper functioning of
the equipment.
The aqueous solution or suspension of the present invention to be
used for being dispensed through the ted apparatus described above
is made by the combination of ingredients selected to provide nourishment in
calibrated proportions, consisting of sugars, protein foods such as yeast and
milk powder, essential oils containing antioxidant active ients and hav-
ing high tonic and healing effect.
Therefore, the invention further concerns a liquid solution or suspen-
sion of nourishment deliverable in a nebulized form through the automated
apparatus proposed, for the prevention and treatment of Colony se
er (CCD), characterized in that it comprises, in a single aqueous solu-
tion or suspension:
a) tonic and nutritious ingredients, mainly consisting of: milk powder
and/or yeasts; sugars and lower organic acids;
b) natural antioxidants and antiseptics contained in the extracts of one
or more aromatic or medicinal plants seiected from: Crocus sativus, Pelargo-
nium graveolens, Monarda citriodora, Myristica fragrans, Origanum vulgare
and Origanum majorana; and
c) curative nces for bees, selected from thymol, oxalic acid, ex-
tracts of Thymus vulgaris, extracts of Aloe arborescens, ts of Beta vul-
garis cv. altissima and mixtures of two or more of the same.
’10 More specifically, the substances used in the preparation according to
the invention are the following:
A. Nutrient and tonic nces
1) Yeast, for example, baker’s yeast, and/or milk powder, of which the
bees are very fond. The level of proteins of the same is about 50%
with a fat content around 7%. Yeasts and milk are the most complete
in terms of amino acids and are rich in B vitamins.
2) Sugar of the glucose or fructose type to increase the paiatability of the
protein element to be administered. it is possible to add pollen and/or
icing sugar se) in an amount ranging from 5% to 15% on the to—
tal dry weight of the formulation. As nutrients vitamin E and essential
amino acids extracted from Aloe scens have also been used,
which are listed below among the substances having curative activity.
3) Acetic acid and/or lower carboxylic or dicarboxyiic acids, C2—Cs. Acetic
acid, tartaric acid and citric acid have the ability to cleave the mole-
cules of e, promoting assimilation by the bees. Also, said acids
are ngals useful in combating the presence of the fungus Nose-
ma and other fungal forms. Specifically, the formulation may contain
acetic acid at a maximum concentration of 6% by weight. A source of
ascorbic acid (vitamin C), such as lemon juice (which contains it, in
on to the most nt citric acid), may be included in the for-
mulation as a vitamin compound, as well as an antioxidant.
4) Among the measures taken to avoid the crystallization of the concen-
-18—
trated solution, one part of water and two parts of sugar can be
brought to a boil for fifteen minutes and add at the end a 5% of glyc-
erol and/or propylene glycol (calculated on the total weight of the con-
centrated formulation). This also has the age of lowering the
freezing point of the entire composition, thus preventing the freezing
of the preparation during the winter
B. Highly active antioxidants and antiseptics
Essential oils with a high content of antioxidants and/or antiseptics
were extracted and added to the formulation, such as noids of the type
of crocetin, crocin and picrocrocin ted from flowers and/or stigmas of
saffron (extracts of Crocus sativus); ial oils as limonene, e.g. extracted
from lemon; geraniol, citronellol, terpineol and linalool, extracted from Pelar-
gonium graveolens (geranium), or from Monarda citriodora var. citriodora;
myristicin, in, geraniol and/or safrole and other aromatic ethers extract-
ed from Myr/stica fragrans (nutmeg); carvacrol, thymol and other minor phe-
nols extracts from Origanum vulgare (ssp hirtum); and terpenes type terpineol,
borneol, sabinene and linalool, extracted from Origanum majorana.
These active ingredients can be ted for example from the plant
species above and usually have a purity exceeding 55%, or they can be made
synthetically.
C. Other therapeutic substances
To ract and/or prevent mites, harmful fungal forms, viruses
including the “VB and lAPV and side effects of neonicotinoids biologically
active substances contained in Thymus vulgaris n thyme) and those
contained in Aloe arborescens (a species of Aloe less common of Aloe vera,
but richer in biological active substances) were used. The first one, whose
essential oil is already widely used in beekeeping, ns two phenolic com-
pounds with biocidal activity, thymol and carvacrol, as well as cineol, borneol
and other terpene compounds.
The second one, Aloe arborescens, contains many biologically active
compounds, including acemannan (a mucopolysaccharide known for its antivi-
ral activity, having an immunomodulator action) and anthraquinones, ing
aloin and emodin, beta-sitosterol, in addition to acetylsalicylic acid. As already
noted, the extracts of this plant also contain all of the essential amino acids
and vitamin E.
Moreover, a good activity was observed according to the invention
with the use of extracts of common beet or Beta vulgaris cv altissima (sugar
beet), containing flavonoids, trimethylglycine, compounds with antioxidant
activity, oxalic acid and B vitamins.
These extracts can also be added with oxalic acid in a quantity not
exceeding 1% of the total of the concentrated formulation, for increasing the
disinfecting effect in synergy with the natural compounds cited.
Preparation of the concentrated solution or suspension - The con-
centrated solution or suspension, which must be subsequently diluted with
water to reach the desired concentrations of the s ingredients, is pre-
pared by the sequential addition of the various nutrients, followed by the anti-
oxidants and the curative compounds, mixing with a bench stirrer in order to
obtain an homogeneous solution (or suspension).
ing to some ic embodiments of the nebulizable on
or sion of the invention, such nutrients and tonic ingredients included in
the formulation consist of milk powder, glucose and/or fructose, acetic acid,
tartaric acid and citric acid. ably, as y noted, the formulation is
added with a small amount of glycerin to avoid crystallization of the concen—
trated intermediate solution.
Preferably, the on or suspension proposed contains the fol-
lowing aromatic and medicinal plant extracts in combination, with functions of
primary antioxidants and/or antiseptics: Crocus sativus extract; Pelargonium
graveo/ens t; ica fragrans extract; Origanum vulgare extract and
Origanum majorana extract. Optionally, to the quoted extracts it is also added
the extract of Monarda citriodora
Additionally, the proposed solution or suspension ns, as curative
substances for bees, Thymus vulgaris extracts, extracts of Aloe arborescens
and oxalic acid, and, according to a red embodiment, also extract of
Beta vulgaris cv. alt/'ssima.
An exemplary formulation of the nutritious and therapeutic preparation
of the invention is shown in the following table, showing the preferred concen-
trations ranges for the various ingredients.
Table 1 — Preferred concentrated formulation
INGREDIENTS PREFERRERED CONCENTRATIONS
(% by weight)
Milk powder 5-10
Distilled water 28-33
Glucose and/or se 53-60
r 2
Glycerine 0.4-0.6
Liquid lemon juice 0.4-0.6
Crocus sativus (crocus) .11
Pelargonium graveolens (geranium) 0.05-0.08
Monarda citriodora (monarda) 0.00—0.08
Myrisz‘ica fragrans (nutmeg) .12
mvulgare (oregano) 0.08—0.12
Origanum majorana (marjoram) 0.08-0.12
Thymol 0.00-0.04
Thymus vulgaris (thyme) 0.03-0.07
Aloe arborescens 0.10-0.20
Beta vulgaris n beet) 0.00-0.30
Oxalic acid 0.00—0.10
According to another aspect complementary to the above, the present
invention consists in a method of treatment of domestic bees es for the
prevention and treatment of Colony Collapse Disorder through the administra—
tion of nutritious and therapeutic nces, which method consists in the
use the automatized apparatus of the invention described above for dispens-
ing in a spray form an aqueous liquid on or suspension containing:
a) tonics and nutritious ients, mainly consisting of: milk powder and/or
yeasts, sugars and lower organic acids;
b) natural antioxidants and antiseptics contained in the extracts of one or more
aromatic or medicinal plants selected from: Crocus sativus, Pelargonium
graveolens, Monarda citriodora, Myristica ns, Origanum is and
um majorana; and
1O c) medicinal substances for bees, selected from thymol, oxalic acid, extracts
of Thymus vulgaris, Aloe arborescens extracts, extracts of Beta vulgaris cv.
altissima and mixtures of two or more f.
In the method of treatment according to the invention, preferred solu—
tions are those in which such nutrient ingredients and tonics consist of milk
powder, glucose and/or fructose, acetic acid, tartaric acid and citric acid.
er, as already noted, such nutrient ingredients and tonics preferably
comprise also glycerin.
According to some preferred embodiments of the method of treatment
and prophylaxis of the invention, the liquid solution or suspension contains the
ts of aromatic or medicinal herbs already mentioned, in ation:
Crocus sativus extract; Pe/argonium graveolens extract; Myristica fragrans
extract; Origanum vulgare extract and Origanum majorana extract. Moreover,
as already noted, the liquid solution or suspension may comprise in addition
extract of Monarda citriodora.
Still according to some specific embodiments of the method of prophy-
laxis and y of the invention, said nces curative for the bees are
preferably extracts of Thymus vulgaris, extracts of Aloe arborescens and oxal-
ic acid. in addition, a preferred variant also contains the extract of Beta vulgar-
is cv. altissima.
By way of examples, which are not to be considered limitative but are
useful to clarify the therapeutic and lactic measures for CCD proposed
according to the invention, two formulations of exemplary solutions are report-
ed in the following, which are suitable to be dispensed through the device
proposed according to the method of the invention. The results of experiments
conducted on the same formulations in field tests are reported as well.
EXAMPLE 1
Concentrated nourishing, antioxidant and curative formulation No. 1
A first formulation to produce one liter of concentrated preparation
to be diluted in 30 liters of water for the final spraying on a number of hives
from 10 up to a maximum of 15 contained the following ingredients in the
following proportions.
A) nts and tonics — to a total of 425 mi:
- aqueous solution at 15% by weight of milk powder 80 ml
- aqueous solution at 90% by weight of sugar 260 ml
- aqueous acetic acid at 6% by weight 20 ml
- in 50 ml
. tartaric acid 5 ml
- citric acid 10 ml
B) idants — to a total of 255 ml:
Essential oils in aqueous solution:
- Crocus s 55 ml,
- Pelargonium 45 ml,
- Monarda citriodora 35 ml,
. Myristica fragrans 45 ml,
- Origanum vulgare ssp hirtum 40 ml,
. Origanum majorana 35 ml;
C) Curative substances - to a total of 320 ml:
Essential oils in s solution:
= Thymus is 100 ml;
= Aloe arborescens 175 ml;
- Beta vulgaris cv a/tissima 25 ml;
aqueous oxalic acid at 3% by weight 20 ml.
Nutrients contained in the milk FORMULAl
lipids
proteins
sugars
The process to obtain the solution involves the sequential addition of
the various nts in the order as indicated above, followed by the antioxi-
dants and ending with the addition of the ve substances. Once added
within a container, they are stirred at room temperature for 5—10 minutes with
a bench stirrer in order to obtain a homogeneous solution of 1000 ml. At this
point the preparation is ready to be further diluted with water, preferably of low
ss, or with ralized water.
EXAMPLE 2
Concentrated nourishing, antioxidant and curative formulation No. 2
A second formulation to make one liter of concentrated preparation
to be diluted in 29 liters of water for the final spraying on a number of hives
from 10 up to a maximum of 15 contained the following ingredients in the
following proportions.
A) Nutrients and - to a total of 425 ml:
- s solution at 15% by weight of milk powder 70 ml
- aqueous solution at 90% by weight of sugar 250 ml
- aqueous acetic acid at 6% by weight 20 ml
- glycerin 50 ml
- citric acid 10 ml
B) Antioxidants —— to a total of 245 ml:
Essential oils in aqueous solution:
- Crocus sativus 55 ml,
= Pe/argonium 35 ml,
a Myristica fragrans 55 ml,
H Origanum vulgare ssp hirtum 75 ml,
= Origanum majorana 25 ml;
C) Curative substances - to a total of 355 ml:
Essential oils in aqueous solution:
- Thymus vulgaris 90 ml;
a Aloe arborescens 245 ml;
oxalic acid at 3% by weight in aqueous solution 20 ml.
lkNutrients ned in the milk } FORMULA ll lipids l 2.28 g
proteins ‘ 2.03 g
sugars l 11.83 g
The process to obtain the final solution es the sequential addi-
tion of the various nutrients in the order as indicated above, followed by the
1O antioxidants and ending with the addition of the curative substances. Once
added within a container, they are stirred at room temperature for 5-10
minutes with a stirrer bench in order to obtain a homogeneous solution of
1000 ml. At this point the preparation is ready to be further diluted with water,
preferably of low ss, or with demineralized water.
Experimentation in the field
Tests have been made since 2009 in ltaly, in Tuscany region at a
location about 200 meters above sea level. The tus according to the
ion has been oned in the proximity of 10 active spruce hives, about
3 meters from the same and was fed continuously with batches of nutritious
and eutic preparation formulated as in Example 1, and thereafter with
batches of preparation formulated as in Example 2.
This equipment has been active until the early months of 2011 and in
the colonies there were no problems related to COD, while in other domestic
bees colonies in the vicinity there was an average loss of more than 20% over
the same two years. At the end of 2010 the number of colonies in the apiary
subjected to treatment according to the invention was increased up to a total
of 14, with a net increase of 40%.
At the beginning of 2011 the apparatus according to the invention was
removed, and as of late March 2011, the same hives were gradually affected
by the depopulation of CCD, and their total number was reduced to only four
units in the month of July 2011. Thus, this finding confirms the initial hypothe-
sis that the treatment method of the invention, as ented through the
proposed automatic nebulizing equipment ly positioned in the vicinity of
colonies of honey bees to be treated, and fed with the described nutrient,
antioxidant and curative formulation is effective to prevent and fight Colony
1O Collapse Disorder.
From the foregoing there follows that the prophylactic and therapeutic
on proposed according to the invention, s countering the afore-
mentioned problems of mites, fungi and llV—6 and lAPV viruses, also es
a remedy to the shortage of food and tonics, and counters the negative effects
of poisoning by the new generation pesticides, allowing to prevent and fight
the onset of Colony Collapse Disorder.
The present invention has been bed with particular reference to
some ments thereof but it should be understood that changes and
modifications may be made by those skilled in the art without departing from
the scope of the invention as described in the appended claims.
Claims (15)
1. A liquid solution or suspension deliverable in a form of a spray, adapted for the prevention and treatment of Colony Collapse Disorder (CCD), the liquid solution or suspension comprising: a) a nutrition composition comprising milk powder, a sugar, C2-Ce or— ganic acid and optionally ; b) an idant and antiseptic composition comprising an extract of Origanum vulgare and an extract of at least one plant selected from the group 10 consisting of Crocus sativus, Pe/argonium graveolens, Monarda dora, Myristica fragrans, and Origanum majorana; and c) a medicinal composition for bees comprising at least one selected from the group consisting of thymol and extracts of Thymus vulgaris, and at least one selected from the group consisting of extracts of Aloe scens, 15 oxalic acid, extracts of Beta vulgar/'3 cv. altissima and mixtures thereof.
2. The liquid solution or suspension according to claim 1, wherein said nutrition composition ses milk powder, acetic acid, ic acid and citric acid and one selected from the group ting of glucose, fructose and a mixture thereof. 20
3. The liquid solution or suspension according to claim 2, wherein said nutrition composition r comprises glycerin.
4. The liquid solution or suspension according to claim 1, wherein said liquid solution or suspension comprises at least two selected from the group consisting of Crocus sativus extract; Pe/argonium graveo/ens extract; Myrisz‘i— 25 ca fragrans extract; and Origanum majorana t.
5. The liquid solution or suspension according to claim 4, further com- prising extract of Monarda citriodora.
6. The liquid solution or suspension ing to claim 1, wherein said nal composition for bees comprises extracts of Thymus vulgar/s, ex- 30 tracts of Aloe scens and oxalic acid.
7. The liquid solution or suspension according to claim 6, wherein said medicinal composition for bees further comprises extract of Beta vulgaris.
8. A method for the prevention and ent of Colony Collapse Disorder (CCD) h the administration of nutrients and eutic sub- stances to bee colonies to be treated, comprising delivering a liquid solution or suspension in a form of a spray, the liquid on or suspension comprising: a) a nutrition composition comprising milk powder, a sugar, C2-Cs or— ganic acid and optionally yeasts; b) an antioxidant and antiseptic composition comprising an extract of Origanum vulgare and an extract of at least one plant selected from the group consisting of Crocus sativus, Pe/argonium graveolens, Monarda citri- 1O odora, Myristica fragrans, and Origanum majorana; and c) a nal composition for bees comprising at least one selected from the group consisting of thymol and ts of Thymus vulgaris, and at least one selected from the group consisting of ts of Aloe arbo- rescens, oxalic acid, extracts of Beta vulgaris cv. altissima and es 15 thereof.
9. The method according to claim 8, wherein said nutrition composi- tion comprises milk powder, acetic acid, tartaric acid and citric acid and one selected from the group consisting of glucose, fructose and a mixture thereof.
10. The method according to claim 9, wherein said nutrition composi— 20 tion further comprises glycerin.
11. The method according to claim 8, comprises at least two selected from the group consisting of Crocus sativus t; onium /ens extract; Myrisz‘ica fragrans extract; and Origanum majorana extract.
12. The method for prevention and treatment according to claim 11, 25 wherein said liquid solution or suspension further comprises extract of Monar- da citriodora.
13. The method for prevention and treatment according to claim 8, wherein said medicinal composition for bees ses extracts of Thymus vulgaris, extracts of Aloe arborescens and oxalic acid. 30
14. The method according to claim 13, wherein said medicinal com- position for bees further comprises extract of Beta vulgaris.
15. The liquid solution or suspension according to any one of claims 1 to 7, substantially as herein described with reference to any of the es thereof. 16, The method according to any one of claims 8 to 14, substantially as herein described with reference to any of the Examples and/or
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000450A ITRM20110450A1 (en) | 2011-08-26 | 2011-08-26 | EQUIPMENT METHOD INGREDIENTS AND FORMULATIONS FOR PRODUCING SOLUTIONS WITH A HIGH NOURISHING AND CURIOUS RECONSTITUTING NOURISHING EFFECT FOR A COMPLETE AND AUTOMATED SYSTEM TO PREVENT AND FIGHT THE BEALS SPLASH SYNDROME |
| NZ62276612 | 2012-03-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NZ719549A NZ719549A (en) | 2018-04-27 |
| NZ719549B2 true NZ719549B2 (en) | 2018-07-31 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9981001B2 (en) | Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder | |
| EP3737241B1 (en) | Solid nutritional composition with acaricide activity for apiculture for use in the prophylaxis and treatment of varroa infestations | |
| Islam et al. | Development of pollen substitute diets for Apis mellifera ligustica colonies and their impact on brood development and honey production. | |
| CN107821335A (en) | A kind of high-yield cultivation method of honeybee | |
| CN108207819A (en) | A kind of cultural method for improving honeybee resistance | |
| CN108522427A (en) | A kind of cultural method of honeybee | |
| Halvacı et al. | Journey to the sweet world of beekeeping: historical development, honey harvesting and overview of bee products | |
| Tiwari et al. | Efficacy of animal origin products and ajwain powder against honey bee diseases in Apis mellifera (Linnaeus) colonies in Uttarakhand-A novel eco-friendly approach | |
| Kartik et al. | Artificial Diet Supplementation: A Review for Sustainable Approach to Boost Honeybee Health | |
| NZ719549B2 (en) | Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder | |
| NZ719549A (en) | Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder | |
| Rana et al. | Artificial diet supplementation: A review for sustainable approach to boost honeybee health: Dearth period and artificial diet for bee health | |
| KR102096721B1 (en) | Low―toxic and eco-friendly composition for controlling Dermanyssus gallinae having Oxalic Acid and method for manufacturing the same | |
| OA17031A (en) | Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder. | |
| US20220211791A1 (en) | Composition against ectoparasites | |
| Adeyemi et al. | Evaluation of the effectiveness of propolis and garlic in the management of maize weevil (Sitophilus zeamais) in stored maize (Zea mays) grains | |
| CN108432706A (en) | A kind of bee raising method improving honey yield | |
| Pradhan et al. | Chapter-1 Apiculture | |
| Chagas et al. | Efficacy evaluation of a commercial neem cake for control of Haematobia irritans on Nelore cattle | |
| US20100104668A1 (en) | Nutritional supplement for honeybees | |
| Sammataro et al. | Honey bee management in the United States | |
| Wongsiri et al. | Organic honey of Thailand | |
| Singh | Applied Zoology | |
| Bisht | Effect of plant and animal origin products on quality of honey, growth parameters and foraging behavior of honey bee Apis mellifera Linnaeus in mustard crop | |
| CN113057183A (en) | Formula of mosquito repellent liquid medicine for repelling mosquitoes and volatilizing core bracelet |